Technology | August 30, 2010

Cardiac Mapping System Launched in Japan

August 30, 2010 - A system was released in Japan last week that helps guide treatment of cardiac arrhythmias by creating a 3-D cardiac map and model based on the information from electrophysiology (EP) catheters.

St. Jude Medical is launching its EnSite Velocity Cardiac Mapping System. Advancements in the technology of both the hardware and software for the EnSite Velocity System were designed to increase procedural Cardiac Mapping System Launched in Japan, increase efficiency and speed, and potentially improve ease of use from set-up and operation to clinical application.

The new system hardware requires less space, offers a simpler set-up, using color-coding for each connector, and has an increased number of input channels. The software offers a completely re-designed and user friendly user interface that has two highly differentiated new capabilities:

OneMap Tool

The new OneMap tool allows physicians to create a detailed cardiac model and electrical map together using information from multiple catheters and electrodes. This feature offers the potential to assist physicians in collecting and displaying a greater amount of information in a shorter amount of time.

RealReview Function

The new RealReview function provides real-time, side-by-side views of the live procedure and previously recorded portions of the procedure. This enables physicians to view a quick and easy comparison of events and results at different times throughout the procedure without losing the ability to visualize and navigate catheters in real-time.

Because of the real time ability to display catheter location, the system has the longstanding ability to reduce fluoroscopy exposure. It also supports both contact and non-contact mapping, giving the EnSite Velocity System the ability to map any arrhythmia. The system’s open platform, offers compatibility with essentially all diagnostic and ablation catheters, recording systems and radiofrequency generators used for cardiac ablation procedures.

For more information:

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems | December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems | October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems | October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems | August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems | July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems | May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems | May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems | February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems | January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems | November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init